Pharma & Healthcare
Global Valsartan-Hydrochlorothiazide Market Research Report 2024
- Jan 18, 24
- ID: 3166
- Pages: 98
- Figures: 223
- Views: 21
This drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: valsartan and hydrochlorothiazide. Valsartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a "water pill" (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water.
The global Valsartan-Hydrochlorothiazide market was valued at US$ 541 million in 2023 and is anticipated to reach US$ 800.5 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valsartan-Hydrochlorothiazide include Novartis, Teva, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Par Pharmaceutical, Huaren Pharmaceutical, Mylan and Alembic Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valsartan-Hydrochlorothiazide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan-Hydrochlorothiazide.
Report Scope
The Valsartan-Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan-Hydrochlorothiazide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan-Hydrochlorothiazide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Teva
Lupin
Aurobindo Pharma
Torrent Pharmaceuticals
Par Pharmaceutical
Huaren Pharmaceutical
Mylan
Alembic Pharmaceuticals
Zhejiang Huahai Pharmaceutical
APOTEX
MACLEODS
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Cisen Pharmaceutical
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan-Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Valsartan-Hydrochlorothiazide market was valued at US$ 541 million in 2023 and is anticipated to reach US$ 800.5 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valsartan-Hydrochlorothiazide include Novartis, Teva, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Par Pharmaceutical, Huaren Pharmaceutical, Mylan and Alembic Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valsartan-Hydrochlorothiazide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan-Hydrochlorothiazide.
Report Scope
The Valsartan-Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan-Hydrochlorothiazide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan-Hydrochlorothiazide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Teva
Lupin
Aurobindo Pharma
Torrent Pharmaceuticals
Par Pharmaceutical
Huaren Pharmaceutical
Mylan
Alembic Pharmaceuticals
Zhejiang Huahai Pharmaceutical
APOTEX
MACLEODS
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Cisen Pharmaceutical
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan-Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Valsartan-Hydrochlorothiazide Market Overview
1.1 Product Overview and Scope of Valsartan-Hydrochlorothiazide
1.2 Valsartan-Hydrochlorothiazide Segment by Type
1.2.1 Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.3 Valsartan-Hydrochlorothiazide Segment by Application
1.3.1 Global Valsartan-Hydrochlorothiazide Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Valsartan-Hydrochlorothiazide Market Size Estimates and Forecasts
1.4.1 Global Valsartan-Hydrochlorothiazide Revenue 2019-2030
1.4.2 Global Valsartan-Hydrochlorothiazide Sales 2019-2030
1.4.3 Global Valsartan-Hydrochlorothiazide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valsartan-Hydrochlorothiazide Market Competition by Manufacturers
2.1 Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valsartan-Hydrochlorothiazide Average Price by Manufacturers (2019-2024)
2.4 Global Valsartan-Hydrochlorothiazide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
2.7 Valsartan-Hydrochlorothiazide Market Competitive Situation and Trends
2.7.1 Valsartan-Hydrochlorothiazide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valsartan-Hydrochlorothiazide Players Market Share by Revenue
2.7.3 Global Valsartan-Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valsartan-Hydrochlorothiazide Retrospective Market Scenario by Region
3.1 Global Valsartan-Hydrochlorothiazide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valsartan-Hydrochlorothiazide Global Valsartan-Hydrochlorothiazide Sales by Region: 2019-2030
3.2.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2019-2024
3.2.2 Global Valsartan-Hydrochlorothiazide Sales by Region: 2025-2030
3.3 Global Valsartan-Hydrochlorothiazide Global Valsartan-Hydrochlorothiazide Revenue by Region: 2019-2030
3.3.1 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2019-2024
3.3.2 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2025-2030
3.4 North America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.4.1 North America Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.4.3 North America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.5.1 Europe Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.5.3 Europe Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.6.1 Asia Pacific Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.6.3 Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.7.1 Latin America Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.7.3 Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2019-2030)
4.1.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2019-2024)
4.1.2 Global Valsartan-Hydrochlorothiazide Sales by Type (2025-2030)
4.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2019-2030)
4.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2019-2030)
4.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Type (2019-2024)
4.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2025-2030)
4.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2019-2030)
4.3 Global Valsartan-Hydrochlorothiazide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2019-2030)
5.1.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2019-2024)
5.1.2 Global Valsartan-Hydrochlorothiazide Sales by Application (2025-2030)
5.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2019-2030)
5.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2019-2030)
5.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Application (2019-2024)
5.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2025-2030)
5.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2019-2030)
5.3 Global Valsartan-Hydrochlorothiazide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Corporation Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Torrent Pharmaceuticals
6.5.1 Torrent Pharmaceuticals Corporation Information
6.5.2 Torrent Pharmaceuticals Description and Business Overview
6.5.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.5.5 Torrent Pharmaceuticals Recent Developments/Updates
6.6 Par Pharmaceutical
6.6.1 Par Pharmaceutical Corporation Information
6.6.2 Par Pharmaceutical Description and Business Overview
6.6.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.6.5 Par Pharmaceutical Recent Developments/Updates
6.7 Huaren Pharmaceutical
6.6.1 Huaren Pharmaceutical Corporation Information
6.6.2 Huaren Pharmaceutical Description and Business Overview
6.6.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.7.5 Huaren Pharmaceutical Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Alembic Pharmaceuticals
6.9.1 Alembic Pharmaceuticals Corporation Information
6.9.2 Alembic Pharmaceuticals Description and Business Overview
6.9.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.9.5 Alembic Pharmaceuticals Recent Developments/Updates
6.10 Zhejiang Huahai Pharmaceutical
6.10.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.10.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.10.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.11 APOTEX
6.11.1 APOTEX Corporation Information
6.11.2 APOTEX Valsartan-Hydrochlorothiazide Description and Business Overview
6.11.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
6.11.5 APOTEX Recent Developments/Updates
6.12 MACLEODS
6.12.1 MACLEODS Corporation Information
6.12.2 MACLEODS Valsartan-Hydrochlorothiazide Description and Business Overview
6.12.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
6.12.5 MACLEODS Recent Developments/Updates
6.13 Chongqing Conquer Pharmaceutical
6.13.1 Chongqing Conquer Pharmaceutical Corporation Information
6.13.2 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.13.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.13.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
6.14 Beijing Second Pharmaceutical
6.14.1 Beijing Second Pharmaceutical Corporation Information
6.14.2 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.14.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.14.5 Beijing Second Pharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Corporation Information
6.15.2 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.15.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan-Hydrochlorothiazide Industry Chain Analysis
7.2 Valsartan-Hydrochlorothiazide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan-Hydrochlorothiazide Production Mode & Process
7.4 Valsartan-Hydrochlorothiazide Sales and Marketing
7.4.1 Valsartan-Hydrochlorothiazide Sales Channels
7.4.2 Valsartan-Hydrochlorothiazide Distributors
7.5 Valsartan-Hydrochlorothiazide Customers
8 Valsartan-Hydrochlorothiazide Market Dynamics
8.1 Valsartan-Hydrochlorothiazide Industry Trends
8.2 Valsartan-Hydrochlorothiazide Market Drivers
8.3 Valsartan-Hydrochlorothiazide Market Challenges
8.4 Valsartan-Hydrochlorothiazide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Valsartan-Hydrochlorothiazide
1.2 Valsartan-Hydrochlorothiazide Segment by Type
1.2.1 Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.3 Valsartan-Hydrochlorothiazide Segment by Application
1.3.1 Global Valsartan-Hydrochlorothiazide Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Valsartan-Hydrochlorothiazide Market Size Estimates and Forecasts
1.4.1 Global Valsartan-Hydrochlorothiazide Revenue 2019-2030
1.4.2 Global Valsartan-Hydrochlorothiazide Sales 2019-2030
1.4.3 Global Valsartan-Hydrochlorothiazide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valsartan-Hydrochlorothiazide Market Competition by Manufacturers
2.1 Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valsartan-Hydrochlorothiazide Average Price by Manufacturers (2019-2024)
2.4 Global Valsartan-Hydrochlorothiazide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
2.7 Valsartan-Hydrochlorothiazide Market Competitive Situation and Trends
2.7.1 Valsartan-Hydrochlorothiazide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valsartan-Hydrochlorothiazide Players Market Share by Revenue
2.7.3 Global Valsartan-Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valsartan-Hydrochlorothiazide Retrospective Market Scenario by Region
3.1 Global Valsartan-Hydrochlorothiazide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valsartan-Hydrochlorothiazide Global Valsartan-Hydrochlorothiazide Sales by Region: 2019-2030
3.2.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2019-2024
3.2.2 Global Valsartan-Hydrochlorothiazide Sales by Region: 2025-2030
3.3 Global Valsartan-Hydrochlorothiazide Global Valsartan-Hydrochlorothiazide Revenue by Region: 2019-2030
3.3.1 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2019-2024
3.3.2 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2025-2030
3.4 North America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.4.1 North America Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.4.3 North America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.5.1 Europe Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.5.3 Europe Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.6.1 Asia Pacific Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.6.3 Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.7.1 Latin America Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.7.3 Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2019-2030)
4.1.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2019-2024)
4.1.2 Global Valsartan-Hydrochlorothiazide Sales by Type (2025-2030)
4.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2019-2030)
4.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2019-2030)
4.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Type (2019-2024)
4.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2025-2030)
4.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2019-2030)
4.3 Global Valsartan-Hydrochlorothiazide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2019-2030)
5.1.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2019-2024)
5.1.2 Global Valsartan-Hydrochlorothiazide Sales by Application (2025-2030)
5.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2019-2030)
5.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2019-2030)
5.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Application (2019-2024)
5.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2025-2030)
5.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2019-2030)
5.3 Global Valsartan-Hydrochlorothiazide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Corporation Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Torrent Pharmaceuticals
6.5.1 Torrent Pharmaceuticals Corporation Information
6.5.2 Torrent Pharmaceuticals Description and Business Overview
6.5.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.5.5 Torrent Pharmaceuticals Recent Developments/Updates
6.6 Par Pharmaceutical
6.6.1 Par Pharmaceutical Corporation Information
6.6.2 Par Pharmaceutical Description and Business Overview
6.6.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.6.5 Par Pharmaceutical Recent Developments/Updates
6.7 Huaren Pharmaceutical
6.6.1 Huaren Pharmaceutical Corporation Information
6.6.2 Huaren Pharmaceutical Description and Business Overview
6.6.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.7.5 Huaren Pharmaceutical Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Alembic Pharmaceuticals
6.9.1 Alembic Pharmaceuticals Corporation Information
6.9.2 Alembic Pharmaceuticals Description and Business Overview
6.9.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.9.5 Alembic Pharmaceuticals Recent Developments/Updates
6.10 Zhejiang Huahai Pharmaceutical
6.10.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.10.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.10.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.11 APOTEX
6.11.1 APOTEX Corporation Information
6.11.2 APOTEX Valsartan-Hydrochlorothiazide Description and Business Overview
6.11.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
6.11.5 APOTEX Recent Developments/Updates
6.12 MACLEODS
6.12.1 MACLEODS Corporation Information
6.12.2 MACLEODS Valsartan-Hydrochlorothiazide Description and Business Overview
6.12.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
6.12.5 MACLEODS Recent Developments/Updates
6.13 Chongqing Conquer Pharmaceutical
6.13.1 Chongqing Conquer Pharmaceutical Corporation Information
6.13.2 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.13.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.13.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
6.14 Beijing Second Pharmaceutical
6.14.1 Beijing Second Pharmaceutical Corporation Information
6.14.2 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.14.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.14.5 Beijing Second Pharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Corporation Information
6.15.2 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Description and Business Overview
6.15.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan-Hydrochlorothiazide Industry Chain Analysis
7.2 Valsartan-Hydrochlorothiazide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan-Hydrochlorothiazide Production Mode & Process
7.4 Valsartan-Hydrochlorothiazide Sales and Marketing
7.4.1 Valsartan-Hydrochlorothiazide Sales Channels
7.4.2 Valsartan-Hydrochlorothiazide Distributors
7.5 Valsartan-Hydrochlorothiazide Customers
8 Valsartan-Hydrochlorothiazide Market Dynamics
8.1 Valsartan-Hydrochlorothiazide Industry Trends
8.2 Valsartan-Hydrochlorothiazide Market Drivers
8.3 Valsartan-Hydrochlorothiazide Market Challenges
8.4 Valsartan-Hydrochlorothiazide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Valsartan-Hydrochlorothiazide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Valsartan-Hydrochlorothiazide Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Valsartan-Hydrochlorothiazide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Valsartan-Hydrochlorothiazide Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Valsartan-Hydrochlorothiazide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
Table 12. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Valsartan-Hydrochlorothiazide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan-Hydrochlorothiazide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Valsartan-Hydrochlorothiazide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Valsartan-Hydrochlorothiazide Sales by Region (2019-2024) & (K Units)
Table 18. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2019-2024)
Table 19. Global Valsartan-Hydrochlorothiazide Sales by Region (2025-2030) & (K Units)
Table 20. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2025-2030)
Table 21. Global Valsartan-Hydrochlorothiazide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2019-2024)
Table 23. Global Valsartan-Hydrochlorothiazide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2025-2030)
Table 25. North America Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 27. North America Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 28. North America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 32. Europe Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 33. Europe Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Type (2019-2024)
Table 51. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Type (2025-2030)
Table 52. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2019-2024)
Table 53. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2025-2030)
Table 54. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2019-2024)
Table 57. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2025-2030)
Table 58. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2019-2024)
Table 59. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2025-2030)
Table 60. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Application (2019-2024)
Table 61. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Application (2025-2030)
Table 62. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2019-2024)
Table 63. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2025-2030)
Table 64. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2019-2024)
Table 67. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2025-2030)
Table 68. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2019-2024)
Table 69. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Valsartan-Hydrochlorothiazide Product
Table 74. Novartis Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Valsartan-Hydrochlorothiazide Product
Table 79. Teva Recent Developments/Updates
Table 80. Lupin Corporation Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Lupin Valsartan-Hydrochlorothiazide Product
Table 84. Lupin Recent Developments/Updates
Table 85. Aurobindo Pharma Corporation Information
Table 86. Aurobindo Pharma Description and Business Overview
Table 87. Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Aurobindo Pharma Valsartan-Hydrochlorothiazide Product
Table 89. Aurobindo Pharma Recent Developments/Updates
Table 90. Torrent Pharmaceuticals Corporation Information
Table 91. Torrent Pharmaceuticals Description and Business Overview
Table 92. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product
Table 94. Torrent Pharmaceuticals Recent Developments/Updates
Table 95. Par Pharmaceutical Corporation Information
Table 96. Par Pharmaceutical Description and Business Overview
Table 97. Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Par Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 99. Par Pharmaceutical Recent Developments/Updates
Table 100. Huaren Pharmaceutical Corporation Information
Table 101. Huaren Pharmaceutical Description and Business Overview
Table 102. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 104. Huaren Pharmaceutical Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Mylan Valsartan-Hydrochlorothiazide Product
Table 109. Mylan Recent Developments/Updates
Table 110. Alembic Pharmaceuticals Corporation Information
Table 111. Alembic Pharmaceuticals Description and Business Overview
Table 112. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product
Table 114. Alembic Pharmaceuticals Recent Developments/Updates
Table 115. Zhejiang Huahai Pharmaceutical Corporation Information
Table 116. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 117. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 119. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 120. APOTEX Corporation Information
Table 121. APOTEX Description and Business Overview
Table 122. APOTEX Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. APOTEX Valsartan-Hydrochlorothiazide Product
Table 124. APOTEX Recent Developments/Updates
Table 125. MACLEODS Corporation Information
Table 126. MACLEODS Description and Business Overview
Table 127. MACLEODS Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. MACLEODS Valsartan-Hydrochlorothiazide Product
Table 129. MACLEODS Recent Developments/Updates
Table 130. Chongqing Conquer Pharmaceutical Corporation Information
Table 131. Chongqing Conquer Pharmaceutical Description and Business Overview
Table 132. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 134. Chongqing Conquer Pharmaceutical Recent Developments/Updates
Table 135. Beijing Second Pharmaceutical Corporation Information
Table 136. Beijing Second Pharmaceutical Description and Business Overview
Table 137. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 139. Beijing Second Pharmaceutical Recent Developments/Updates
Table 140. Cisen Pharmaceutical Corporation Information
Table 141. Cisen Pharmaceutical Description and Business Overview
Table 142. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 144. Cisen Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Valsartan-Hydrochlorothiazide Distributors List
Table 148. Valsartan-Hydrochlorothiazide Customers List
Table 149. Valsartan-Hydrochlorothiazide Market Trends
Table 150. Valsartan-Hydrochlorothiazide Market Drivers
Table 151. Valsartan-Hydrochlorothiazide Market Challenges
Table 152. Valsartan-Hydrochlorothiazide Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Valsartan-Hydrochlorothiazide
Figure 2. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Valsartan-Hydrochlorothiazide Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Valsartan-Hydrochlorothiazide Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Valsartan-Hydrochlorothiazide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Valsartan-Hydrochlorothiazide Market Size (2019-2030) & (US$ Million)
Figure 12. Global Valsartan-Hydrochlorothiazide Sales (2019-2030) & (K Units)
Figure 13. Global Valsartan-Hydrochlorothiazide Average Price (USD/Unit) & (2019-2030)
Figure 14. Valsartan-Hydrochlorothiazide Report Years Considered
Figure 15. Valsartan-Hydrochlorothiazide Sales Share by Manufacturers in 2023
Figure 16. Global Valsartan-Hydrochlorothiazide Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Valsartan-Hydrochlorothiazide Players: Market Share by Revenue in 2023
Figure 18. Valsartan-Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Valsartan-Hydrochlorothiazide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 21. North America Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 25. Europe Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 26. Germany Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Valsartan-Hydrochlorothiazide Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2019-2030)
Figure 33. China Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 44. Latin America Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Valsartan-Hydrochlorothiazide by Type (2019-2030)
Figure 54. Global Revenue Market Share of Valsartan-Hydrochlorothiazide by Type (2019-2030)
Figure 55. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Valsartan-Hydrochlorothiazide by Application (2019-2030)
Figure 57. Global Revenue Market Share of Valsartan-Hydrochlorothiazide by Application (2019-2030)
Figure 58. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2019-2030)
Figure 59. Valsartan-Hydrochlorothiazide Value Chain
Figure 60. Valsartan-Hydrochlorothiazide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Valsartan-Hydrochlorothiazide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Valsartan-Hydrochlorothiazide Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Valsartan-Hydrochlorothiazide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Valsartan-Hydrochlorothiazide Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Valsartan-Hydrochlorothiazide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
Table 12. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Valsartan-Hydrochlorothiazide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan-Hydrochlorothiazide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Valsartan-Hydrochlorothiazide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Valsartan-Hydrochlorothiazide Sales by Region (2019-2024) & (K Units)
Table 18. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2019-2024)
Table 19. Global Valsartan-Hydrochlorothiazide Sales by Region (2025-2030) & (K Units)
Table 20. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2025-2030)
Table 21. Global Valsartan-Hydrochlorothiazide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2019-2024)
Table 23. Global Valsartan-Hydrochlorothiazide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2025-2030)
Table 25. North America Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 27. North America Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 28. North America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 32. Europe Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 33. Europe Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Valsartan-Hydrochlorothiazide Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Valsartan-Hydrochlorothiazide Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Type (2019-2024)
Table 51. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Type (2025-2030)
Table 52. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2019-2024)
Table 53. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2025-2030)
Table 54. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2019-2024)
Table 57. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2025-2030)
Table 58. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2019-2024)
Table 59. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2025-2030)
Table 60. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Application (2019-2024)
Table 61. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Application (2025-2030)
Table 62. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2019-2024)
Table 63. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2025-2030)
Table 64. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2019-2024)
Table 67. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2025-2030)
Table 68. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2019-2024)
Table 69. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Valsartan-Hydrochlorothiazide Product
Table 74. Novartis Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Valsartan-Hydrochlorothiazide Product
Table 79. Teva Recent Developments/Updates
Table 80. Lupin Corporation Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Lupin Valsartan-Hydrochlorothiazide Product
Table 84. Lupin Recent Developments/Updates
Table 85. Aurobindo Pharma Corporation Information
Table 86. Aurobindo Pharma Description and Business Overview
Table 87. Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Aurobindo Pharma Valsartan-Hydrochlorothiazide Product
Table 89. Aurobindo Pharma Recent Developments/Updates
Table 90. Torrent Pharmaceuticals Corporation Information
Table 91. Torrent Pharmaceuticals Description and Business Overview
Table 92. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product
Table 94. Torrent Pharmaceuticals Recent Developments/Updates
Table 95. Par Pharmaceutical Corporation Information
Table 96. Par Pharmaceutical Description and Business Overview
Table 97. Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Par Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 99. Par Pharmaceutical Recent Developments/Updates
Table 100. Huaren Pharmaceutical Corporation Information
Table 101. Huaren Pharmaceutical Description and Business Overview
Table 102. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 104. Huaren Pharmaceutical Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Mylan Valsartan-Hydrochlorothiazide Product
Table 109. Mylan Recent Developments/Updates
Table 110. Alembic Pharmaceuticals Corporation Information
Table 111. Alembic Pharmaceuticals Description and Business Overview
Table 112. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product
Table 114. Alembic Pharmaceuticals Recent Developments/Updates
Table 115. Zhejiang Huahai Pharmaceutical Corporation Information
Table 116. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 117. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 119. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 120. APOTEX Corporation Information
Table 121. APOTEX Description and Business Overview
Table 122. APOTEX Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. APOTEX Valsartan-Hydrochlorothiazide Product
Table 124. APOTEX Recent Developments/Updates
Table 125. MACLEODS Corporation Information
Table 126. MACLEODS Description and Business Overview
Table 127. MACLEODS Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. MACLEODS Valsartan-Hydrochlorothiazide Product
Table 129. MACLEODS Recent Developments/Updates
Table 130. Chongqing Conquer Pharmaceutical Corporation Information
Table 131. Chongqing Conquer Pharmaceutical Description and Business Overview
Table 132. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 134. Chongqing Conquer Pharmaceutical Recent Developments/Updates
Table 135. Beijing Second Pharmaceutical Corporation Information
Table 136. Beijing Second Pharmaceutical Description and Business Overview
Table 137. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 139. Beijing Second Pharmaceutical Recent Developments/Updates
Table 140. Cisen Pharmaceutical Corporation Information
Table 141. Cisen Pharmaceutical Description and Business Overview
Table 142. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product
Table 144. Cisen Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Valsartan-Hydrochlorothiazide Distributors List
Table 148. Valsartan-Hydrochlorothiazide Customers List
Table 149. Valsartan-Hydrochlorothiazide Market Trends
Table 150. Valsartan-Hydrochlorothiazide Market Drivers
Table 151. Valsartan-Hydrochlorothiazide Market Challenges
Table 152. Valsartan-Hydrochlorothiazide Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Valsartan-Hydrochlorothiazide
Figure 2. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Valsartan-Hydrochlorothiazide Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Valsartan-Hydrochlorothiazide Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Valsartan-Hydrochlorothiazide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Valsartan-Hydrochlorothiazide Market Size (2019-2030) & (US$ Million)
Figure 12. Global Valsartan-Hydrochlorothiazide Sales (2019-2030) & (K Units)
Figure 13. Global Valsartan-Hydrochlorothiazide Average Price (USD/Unit) & (2019-2030)
Figure 14. Valsartan-Hydrochlorothiazide Report Years Considered
Figure 15. Valsartan-Hydrochlorothiazide Sales Share by Manufacturers in 2023
Figure 16. Global Valsartan-Hydrochlorothiazide Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Valsartan-Hydrochlorothiazide Players: Market Share by Revenue in 2023
Figure 18. Valsartan-Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Valsartan-Hydrochlorothiazide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 21. North America Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 25. Europe Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 26. Germany Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Valsartan-Hydrochlorothiazide Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2019-2030)
Figure 33. China Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 44. Latin America Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Valsartan-Hydrochlorothiazide Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Valsartan-Hydrochlorothiazide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Valsartan-Hydrochlorothiazide by Type (2019-2030)
Figure 54. Global Revenue Market Share of Valsartan-Hydrochlorothiazide by Type (2019-2030)
Figure 55. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Valsartan-Hydrochlorothiazide by Application (2019-2030)
Figure 57. Global Revenue Market Share of Valsartan-Hydrochlorothiazide by Application (2019-2030)
Figure 58. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2019-2030)
Figure 59. Valsartan-Hydrochlorothiazide Value Chain
Figure 60. Valsartan-Hydrochlorothiazide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232